A new book critiques medicine
blogs.scientificamerican.com
A new book critiques medicine
1–10 of 198 posts
Re: A new book critiques medicine
#2Researchers have labored mightily to find more magic bullets, but they remain rare. For example, imatinib, brand name Gleevec, is “an especially effective treatment” for one type of leukemia, Stegenga says. But Gleevec has “severe adverse effects, including nausea, headaches, severe cardiac failure and delayed growth in children.”
Most would prefer these symptoms over death.
https://en.wikipedia.org/wiki/Betteridge%27s_law_of_headline...
Re: A new book critiques medicine
#3Re: A new book critiques medicine
#4Re: A new book critiques medicine
#5Re: A new book critiques medicine
#6Note that the author is a “science journalist” with a degree in journalism, not medicine or even STEM.
Re: A new book critiques medicine
#7We need to be careful how we say this, because then you get generalities like the title and people who shun the basic of medicines such as neccessary vacinations.
Re: A new book critiques medicine
#8A couple of days ago we got the: "Fat Is Not the Problem—Fat Stigma Is", now this article. What follows, "Aliens may have built the Pyramids after all"?
Re: A new book critiques medicine
#9HIPAA laws are hiding patient outcomes and holding this whole sham afloat.
Re: A new book critiques medicine
#10Stegenga calls these latter two “magic bullets,” a phrase coined by physician/chemist Paul Ehrlich to describe treatments that target the cause of a disease without disrupting the body’s healthy functions. Researchers have labored mightily to find more magic bullets, but they remain rare. For example, imatinib, brand name Gleevec, is “an especially effective treatment” for one type of leukemia, Stegenga says. But Gle…